AstraZeneca vaccine withdrawn globally over side effect

AstraZeneca has admitted in court documents that its Covid-19 vaccine, developed in collaboration with Oxford University and manufactured as Covishield in India, can cause a rare and dangerous side effect known as Thrombosis with Thrombocytopenia Syndrome. Pharmaceutical giant on Wednesday further announced the global withdrawal of its vaccine. The Serum Institute and the Indian government are yet to make a comment on the development.

Written by: Tonata Kadhila

AstraZeneca COVID-19 Vaccine Covishield India Oxford Serum Institute Thrombocytopenia Thrombosis Vaccine Side Effects

Biosafety Act of 2006 requires review and modernisation says Aupindi

By: Selma Taapopi Chairperson of the Parliamentary Standing Committee on Natural Resources, Tobie Aupindi, says the Biosafety Act of 2006 (Act No. 7 of 2006) and its subsequent regulations have served Namibia well over the years. He however noted that rapid scientific advancements have exposed the need to review and […]

24 February, 2026